[Infants of diabetic mothers (IDM). II -- Fibronectin and perinatal morbidity].
OBJECTIVE
The objective of this study was to determine fibronectin levels in umbilical cord blood of infants of diabetic mothers (IDM) and evaluate a possible correlation with perinatal pathology.


METHODS
A prospective study of 58 IDM (33 males and 25 females) and 58 control newborns (NB) (33 males and 25 females) was carried out.


RESULTS
There were no differences in fibronectin levels between the two groups nor between the sexes. Perinatal morbidity was higher in the IDM group, but there was no correlation between fibronectin levels and the presence of perinatal pathology.


CONCLUSIONS
Fibronectin levels are not useful in the perinatal evaluation of infants of diabetic mothers.
Martín Carballo
G
G
Servicio de Endocrinología, Hospital Infantil La Paz, Madrid.
Codoceo Alquila
R
R
Fernández Cano
G
G
Hawkins Carranza
F
F
Grande Aragón
C
C
Velasco Hernando
A
A
Gracia Bouthelier
R
R
D003924:Diabetes Mellitus, Type 2; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005353:Fibronectins / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000453:epidemiology*; D008297:Male; D011446:Prospective Studies
D005353:Fibronectins
El recién nacido hijo de madre diabética (RNHMD). II--Fibronectina y morbilidad perinatal.